A-RAF |
V-Raf murine sarcoma 3611 viral oncogene homolog 1 |
AKT |
Protein kinase B |
ALK |
Anaplastic lymphoma receptor tyrosine kinase |
AMPK |
AMP-activated protein kinase |
APC/C |
Anaphase-promoting complex/cyclosome |
ASK1 |
Apoptosis signal-regulating kinase 1 |
ASO |
Antisense-oligonucleotide |
B-RAF |
V-Raf murine sarcoma viral oncogene homolog B |
Bad |
BCL2-associated agonist of cell death |
BCL-XL |
B-cell lymphoma-extra large |
BCL2 |
B-cell lymphoma 2 |
BET |
Bromodomain and extraterminal domain |
BRCA |
Breast cancer gene |
C-RAF |
V-Raf-1 murine leukemia viral oncogene-like protein 1 |
CDC25C |
M-phase inducer phosphatase 3 |
CDK |
Cyclin-dependent kinase |
CDKN2A/B |
Cyclin-dependent kinase inhibitor 2A/B |
Chk1 |
Checkpoint kinase 1 |
CRISPR/Cas9 |
Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 |
CSC |
Cancer stem-like cell |
CTLA-4 |
Cytotoxic T-lymphocyte-associated protein 4 |
DDR1 |
Discoidin domain receptor 1 |
EGFR |
Epidermal growth factor receptor |
ERK |
Extracellular regulated kinase |
FAK |
Focal adhesion kinase |
FDA |
U.S. Food and Drug Administration |
FGFR |
Fibroblast growth factor receptor |
FTI |
Farnesyltransferase inhibitor |
G12C |
Glycine 12 to cysteine |
G12D |
Glycine 12 to aspartic acid |
G12V |
Glycine 12 to valine |
GAP |
GTPase-activating protein |
GATA2 |
GATA-binding protein 2 |
GDP |
Guanosine diphosphate |
GEF |
Guanine nucleotide exchange factor |
GGTase I |
Geranylgeranyltransferase I |
GTP |
Guanosine triphosphate |
HER2–4/ERBB2–4 |
Human epidermal growth factor receptors 2–4 |
HLA |
Human leukocyte antigen |
HRAS |
Harvey rat sarcoma viral oncogene homolog |
HSP90 |
Heat shock protein 90 |
ICMT1 |
Isoprenyl carboxyl methyltransferase |
IGF1R |
Insulin-like growth factor 1 receptor |
IKK |
IkappaB kinase |
IκB |
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor |
JNK |
c-Jun N-terminal kinase |
KEAP1 |
Kelch-like ECH-associated protein 1 |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
LKB1 |
Liver kinase B1 |
MAP3K7 |
Mitogen-activated protein kinase kinase kinase 7 |
MAPK |
Mitogen-activated protein kinase |
MEK |
Mitogen-activated protein kinase kinase |
MHC II |
Major histocompatibility complex class II |
mTOR |
Mechanistic target of rapamycin kinase |
NF-κB |
Nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells |
NRAS |
Neuroblastoma rat sarcoma viral oncogene homolog |
NSCLC |
Non-small-cell lung cancer |
ORR |
Objective response rate |
p53 |
Tumor protein p53 |
p90RSK |
p90 ribosomal S6 kinase |
PARP |
Poly(ADP-ribose)polymerase |
PD-1 |
Programmed cell death protein 1 |
PD-L1 |
Programmed cell death 1 ligand 1 |
PDX |
Patient-derived xenograft |
pERK |
Phosphorylated ERK |
PFS |
Progression-free survival |
PI3K |
Phosphoinositide 3-kinase |
PLD1 |
Phospholipase D1 |
PLK1 |
Polo-like kinase 1 |
PROTAC |
Proteolysis-targeting chimera |
PTEN |
Phosphatase and tensin homolog |
PTPN11 |
Protein tyrosine phosphatase non-receptor type 11 |
RAC |
Ras-related C3 botulinum toxin substrate 1 |
RAF |
Rat fibrosarcoma |
RAL |
Ras-like protein |
RALGDS |
Ral guanine nucleotide dissociation stimulator |
RBD |
RAS-binding domain |
RCE1 |
RAS-converting enzyme 1 |
RET |
RET proto-oncogene |
RHOA |
Ras homolog family member |
RNAi |
RNA interference |
ROCK2 |
Rho-associated coiled-coil containing protein kinase 2 |
ROS |
Proto-oncogene tyrosine-protein kinase ROS |
RTK |
Receptor tyrosine kinase |
SNAIL2 |
Snail family transcriptional repressor 2 |
SRC |
V-Src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
STK11 |
Serine/threonine kinase 11 |
STK3 |
Serine/threonine-protein kinase 3 |
TBK1 |
TANK binding kinase 1 |
TCA |
Tricarboxylic acid cycle |
TCR |
T cell receptor |
Th17 |
T helper 17 |
TIAM1 |
T lymphoma invasion and metastasis-inducing protein 1 |
Tim-3 |
T cell immunoglobulin mucin-3 |
TKI |
Tyrosine kinase inhibitor |
TPX2 |
Targeting protein for Xklp2 |
Treg |
Regulatory T cells |
ULK1 |
Unc-51-like autophagy activating kinase 1 |
VHL |
von Hippel–Lindau disease tumor suppressor |
WT1 |
Wilms tumor 1 |